Cellebrite DI Sees Q3 Sales $145.000M-$148.000M vs $150.298M Est
Cellebrite DI (NASDAQ:CLBT) sees Q3 sales of $145.000 million-$148.000 million vs $150.298 million analyst estimate.
Cellebrite expects to make a bit less money than experts predicted this quarter. When a company misses what people expected, it can mean they faced challenges—which is worth noticing when you track how the company is doing.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.